SCHEMBL26009028

SCHEMBL26009028

CN(C(=O)OCC1c2ccccc2-c2ccccc21)[C@H](CCCCN)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
TLR2 O60603 2/20 0.42
FABP5 Q01469 3/20 0.40
FABP7 O15540 2/20 0.40
EPOR P19235 2/20 0.38
FOLH1 Q04609 1/20 0.37
CASP3 P42574 1/20 0.37
MDM2 Q00987 2/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30140912 1.00 KMT2A (0.43) KMT2ATLR2FABP5FABP7EPOR
SCHEMBL30350460 1.00 KMT2A (0.43) KMT2ATLR2FABP5FABP7EPOR
SCHEMBL31714158 1.00 KMT2A (0.43) KMT2ATLR2FABP5FABP7EPOR
Hydrochloric Acid SCHEMBL25357186 0.99 TLR2 (0.43) KMT2ATLR2FABP5FABP7EPOR
Hydrochloric Acid SCHEMBL25359281 0.99 TLR2 (0.43) KMT2ATLR2FABP5FABP7EPOR
Hydrochloric Acid SCHEMBL25357179 0.99 TLR2 (0.43) KMT2ATLR2FABP5FABP7EPOR
SCHEMBL27887204 0.97 KMT2A (0.44) KMT2ATLR2FABP5FABP7CASP3
SCHEMBL30927075 0.97 KMT2A (0.44) KMT2ATLR2FABP5FABP7CASP3
SCHEMBL25182297 0.90 TLR2 (0.43) KMT2ATLR2FABP5FABP7FOLH1
SCHEMBL30792938 0.90 TLR2 (0.43) KMT2ATLR2FABP5FABP7FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP KMT2A 3083/4885TLR2 3866/4885FABP5 767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.